NCT06894810Recruiting
Investigating the Efficacy of a Paediatric Fertility Preservation Decision Aid in Parents and Adolescents and Young Adults (CAYA) Cancer Survivors
A Double Blind Randomised Controlled Trial of a Paediatric Fertility Preservation Decision Aid in Parents and Adolescents and Young Adults (CAYA) Cancer Survivors
Source: ClinicalTrials.gov · Last updated 16 Oct 2026
Brief summary (registry, in English)
The current standard of care for paediatric patients with cancer regarding preservation of their fertility (FP) is to provide high-quality information during the clinical consultation process. However, this approach depends on health provider knowledge and communication and has been shown to be sub-optimal in some situations. This impairs the critical decision-making of patients regarding fertility testing, utilization of gametes, and continuing payment of storage fees. The fertility preservation decision aid (FP DA) may lead to a greater understanding of their fertility status for participants. This knowledge may allow participants the opportunity to assess potential fertility issues prior to the end of their reproductive window, helping to minimize missed opportunities for parenthood. This research study aims to assess the effectiveness of the use of the FP DA on unmet fertility information needs when it is provided in addition to high-quality information in parents of cancer survivors and CAYA cancer survivors compared to high-quality information alone.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 358 (estimated)
- First submitted
- 20 Feb 2025
- Start date
- 8 Dec 2025
- Primary completion date
- Jun 2027
- Lead sponsor
- Murdoch Childrens Research Institute
- Diseases
- Childhood cancers
- NCT number
- NCT06894810
What you commit to
- Study type: Interventional
- Planned participants: 358
- From 8 Dec 2025 to the primary completion date, Jun 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- CAYA patients currently undergoing cancer treatment and their parents/guardians.
Other
- CAYA patients who are palliative and their parents/guardians
- A family member already in the study.
- Minors who are not deemed to be mature minors as per protocol
Who the study is looking for
- Be able to communicate in English.
- Signed written informed consent form.
- Parents/guardians of CAYA survivors who were ≤25 years (2) when diagnosed with cancer and have completed curative gonadotoxic treatment
- CAYA cancer survivors aged 16 years or over who have completed curative gonadotoxic treatment.
- Participants can be on long-term adjuvant or endocrine therapy.
- Participants may have achieved a pregnancy or livebirth.
Age in the registry: 16 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Murdoch Children's Research Institute Coordinator of this site? Confirm its status | Melbourne | Australia | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.